Even at rest, most of your muscles are in a state of partial contraction called muscle
tonus. This tonus is maintained by the constant activation
of a small number of motor units that contract alternately.
The muscle fibres that make up a particular motor unit are not physically located right next to each other, but rather scattered at various locations in the muscle. This arrangement makes functional sense when you consider how much energy must be provided to make a muscle contract. This energy comes from the combustion of glucose, which is carried to the muscle fibres by the blood capillaries running between them.
Since by definition, all the muscle fibres making up a given motor unit are innervated by the same motor neuron and contract at the same time, if they were physically adjacent, then when they contracted, their thickening would compress the capillaries supplying them with energy.
This sudden reduction in their energy supply would produce rapid fatigue in the motor unit. The scattered distribution of the unit's fibres throughout the muscle avoids this problem.
THE ROLE OF THE NEUROMUSCULAR JUNCTION IN MUSCLE CONTRACTION
The contraction of a motor
unit in a muscle is initiated by the release of acetylcholine
into the neuromuscular junction.
The
acetylcholine activates cholinergic
nicotinic receptors in the motor end plate of the muscle
fibre, triggering an excitatory potential in its post-synaptic
membrane, the sarcolemma. If this potential reaches a certain
threshold, a muscular action potential is generated by the
potential-dependent sodium channels in this membrane.
This action potential travels first over the surface of the
sarcolemma and then over that of the T tubules, causing calcium
stored in the sarcoplasmic reticulum to be released. This calcium
diffuses into the myofibrils, which are divided by Z
stripes into segments called sarcomeres.
In each sarcomere, thick and thin filaments then slide past
each other, thus drawing the Z stripes closer together, reducing
the length of the sarcomere, and causing the muscle to contract.
To understand how the calcium causes these thick and thin filaments
to slide past each other, we must consider the proteins of which
they are composed. The thick filaments consist mostly of myosin,
while the thin filaments consist mostly of actin.
Each myosin molecule has a "head" at either end, including
a site that can bind with actin.
When no calcium is present, the myosin in the thick filaments
cannot bind with the actin in the thin ones, because the binding
sites on the actin molecules are occupied by another protein, troponin.
But when calcium is released by a muscular action potential, it
binds to the troponin, thereby accomplishing two things: 1) exposing
the actin-binding sites on the myosin molecule heads; and 2) altering
the form of another protein, tropomyosin, so that
it exposes the myosin-binding sites on the actin molecules.
The myosin heads can then bind to the sites on the actin molecules.
In this process, these heads undergo a change in conformation that
makes them rotate. It is this rotation that pulls the thin actin
filaments past the thick myosin filaments, one notch at a time,
like a ratchet mechanism, causing the muscle to contract.
The contraction will continue as long as calcium and ATP are available.
One of the functions of the ATP is to break the bond between the
myosin and the actin. (This explains why the muscles of a dead
body become rigid as the supply of ATP begins to run short.)
The amount of calcium released by the sarcoplasmic reticulum depends
on the frequency of the action potentials in the muscle fibre.
(If this frequency reaches or exceeds 50 stimuli per second, it
is high enough to cause a sustained muscle contraction, known as
a tetanus.)
The muscle contraction ends when the action potentials cease and
the concentration of calcium in the myofibrils diminishes. This
reduction in calcium is due to its being recaptured by the sarcoplasmic
reticulum, an active process that requires ATP. When the calcium
concentration returns to normal, the muscle fibre returns to its
relaxed position.
Myasthenia
gravis is a disease associated with a malfunction in the
transmission of impulses from the nerves to the voluntary
muscles. It is considered an auto-immune disease, because
in patients who have it, certain white blood corpuscles manufacture
antibodies against the body's own acetylcholine receptors,
thus destroying them. The efficiency of the neuromuscular
junctions is thereby reduced, causing muscle weakness during
physical effort or, in the most serious forms of the illness,
a permanent reduction in muscle strength.
Certain toxic gases such
as sarin act by preventing acetylcholinesterase from hydrolyzing
acetylcholine, thus causing constant stimulation of the
receptors and violent muscle spasms.
Miniature electrical
currents, each corresponding to the spontaneous release
of one acetylcholine (ACh) vesicle, can be recorded at
the postsynaptic motor end plate of the neuromuscular junction
in the absence of any stimulation of the presynaptic motor
axon. Each of these miniature currents corresponds to the
opening of about 1 600 nicotinic receptor channels
by the effect of ACh. Since it takes two ACh molecules
to open one such channel, it follows that one vesicle contains
3 200 molecules of ACh. The spike in the current at
the motor end plate represents about 100 miniature currents,
or the release of about 320 000 molecules of ACh opening
about
160 000 nicotinic receptors.
NICOTINIC ACETYLCHOLINE
RECEPTORS
At the neuromuscular junction,
acetylcholine is synthesized in the cytoplasm of the axon's terminal
button, from acetyl coenzyme A and choline. (About half of this
choline has been recaptured by the terminal button after previously
produced acetylcholine was hydrolyzed by the enzyme acetylcholinesterase
in the synaptic gap.) Many thousands of molecules of acetylcholine
are thus stored in each synaptic vesicle (see sidebar).
As soon as the vesicles'
contents are released into the synaptic gap, about half of
the acetylcholine molecules are hydrolyzed by acetylcholinesterase.
But soon so many acetylcholine molecules accumulate that this
enzyme cannot break them all down, and the remaining half reach
the nicotinic acetylcholine receptors on the postsynaptic side
of the gap. Of course, all of this happens very quickly. Acetylcholinesterase
can hydrolyze 4000 molecules of acetylcholine per site per
second, so the half-life of the acetylcholine is estimated
at 1 or 2 milliseconds. In fact, the distribution of the acetylcholinesterase
perfectly matches that of the postsynaptic nicotinic receptors.
Thus, in the case of acetycholine, synaptic
transmission is terminated chiefly by a biochemical reaction.
In contrast, for catecholamines, the main mechanisms are diffusion
of the neurotransmitter outside the synaptic gap and, primarily,
its recapture by the presynaptic button.
Acetylcholine receptors are divided into two major families: nicotinic
and muscarinic. The acetylcholine receptors in neuromuscular
junctions are nicotinic. They consist of pentameric proteins
that form an ion channel embedded in a lipid bilayer in the
postsynaptic membrane. These receptors number nearly 10 000/µm2.
The acetylcholine binds to the extracellular part of the two
alpha subunits of this channel protein, which has 5
subunits in all.
Each subunit in turn consists of four helicoidal transmembrane
domains, designated M1 to M4. It is the M2 domains of the five
subunits that together form the wall of the ion channel. This ion
channel, which is opened by the allosteric conformation change
triggered by the binding of the acetylcholine, is equally permeable
to sodium and potassium. Its permeability to calcium accounts for
only 2.5% of its total permeability. The half-life of adult nicotinic
receptors is 4 to 6 days.